@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_head { this: np:hasAssertion dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_assertion; np:hasProvenance dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_provenance; np:hasPublicationInfo dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_publicationInfo; a np:Nanopublication . dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_assertion a np:Assertion . dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_provenance a np:Provenance . dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_publicationInfo a np:PublicationInfo . } dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_assertion { miriam-gene:35 a ncit:C16612 . lld:C0220710 a ncit:C7057 . dgn-gda:DGN0b7b1602bcc4c6f681993588eb22b6a7 sio:SIO_000628 miriam-gene:35, lld:C0220710; a sio:SIO_001122 . } dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_provenance { dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_assertion dcterms:description "[These gene variants were detected in either homozygous or compound heterozygous form in 7% of the study population. Additionally, the frequency of the 625G>A allele in the Hispanic population (30%) was significantly higher than that of the African-American (9%) and Asian (13%) subpopulations. A previously unreported variant, IVS 5 (-10) C>T, was identified in three African-American newborns (0.3%). The C(4)-acylcarnitine concentration in blood spots was significantly higher in subjects homozygous for the 625A variant when compared to those homozygous for the wild type (p<0.0001). However, none of the observed genotypes was associated with a concentration of C(4)-acylcarnitine that would be consistent with a biochemical diagnosis of SCAD deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:12706374; prov:wasDerivedFrom dgn-void:gad-20130706; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:gad-20130706 pav:importedOn "2013-07-06"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP49704.RAmqmrXf9pyloLDfqivjqYIroTc6ixU0gMuXLuFS3Iut8130_publicationInfo { this: dcterms:created "2014-10-02T12:32:23+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }